Listing Thumbnail

    BrainSeq - Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders

     Info
    Open data
    |
    Deployed on AWS
    This ambitious project seeks to characterize the genetic and epigenetic regulation of multiple facets of transcription in distinct brain regions across the human lifespan in samples of major neuropsychiatric disorders and controls. Initially focused on schizophrenia and mood disorders, the goal of this consortium is to elucidate the underlying molecular mechanisms of genetic associations with the goal of identifying novel therapeutic targets. The consortium currently consists of seven pharmaceutical companies and a not-for-profit medical research institution working as a precompetitive team to generate and analyze publicly available archival brain genomic data related to neuropsychiatric illness.

    Overview

    This ambitious project seeks to characterize the genetic and epigenetic regulation of multiple facets of transcription in distinct brain regions across the human lifespan in samples of major neuropsychiatric disorders and controls. Initially focused on schizophrenia and mood disorders, the goal of this consortium is to elucidate the underlying molecular mechanisms of genetic associations with the goal of identifying novel therapeutic targets. The consortium currently consists of seven pharmaceutical companies and a not-for-profit medical research institution working as a precompetitive team to generate and analyze publicly available archival brain genomic data related to neuropsychiatric illness.

    Features and programs

    Open Data Sponsorship Program

    This dataset is part of the Open Data Sponsorship Program, an AWS program that covers the cost of storage for publicly available high-value cloud-optimized datasets.

    Pricing

    This is a publicly available data set. No subscription is required.

    How can we make this page better?

    Tell us how we can improve this page, or report an issue with this product.
    Tell us how we can improve this page, or report an issue with this product.

    Legal

    Content disclaimer

    Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.

    Usage information

     Info

    Delivery details

    AWS Data Exchange (ADX)

    AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.

    Open data resources

    Available with or without an AWS account.

    How to use
    To access these resources, reference the Amazon Resource Name (ARN) using the AWS Command Line Interface (CLI). Learn more 
    Description
    Phase 1: DLPFC polyA+ RNA-seq on 738 subjects spanning the lifespan and three main psychiatric diagnostic groups (Schizophrenia, Major Depression Disorder, and Bipolar Disorder).
    Resource type
    S3 bucket
    Amazon Resource Name (ARN)
    arn:aws:s3:::brainseq.opendata.sagebase.org
    AWS region
    us-east-1
    AWS CLI access (No AWS account required)
    aws s3 ls --no-sign-request s3://brainseq.opendata.sagebase.org/

    Resources

    Support

    Managed By

    Sage Bionetworks

    How to cite

    BrainSeq - Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders was accessed on DATE from https://registry.opendata.aws/brainseq .

    License

    CC BY

    Similar products